PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
Clinical trial NCT01915901 · COMPLETED
Trial details
- NCT number
- NCT01915901
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.